Your new experience awaits. Try the new design now and help us make it even better

MINI REVIEW article

Front. Endocrinol.

Sec. Pediatric Endocrinology

Unlocking the Heterogeneity of Pediatric Obesity:A Phenotypic Subtype-Based Paradigm for Precision Management

Provisionally accepted
祎  张祎 张1jiaqi  zhangjiaqi zhang1Xiaolu  YuXiaolu Yu1Jie  ZhangJie Zhang1Hongtao  CuiHongtao Cui2*Yan  XuYan Xu1,3*
  • 1First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China
  • 2Chongqing City Hospital of Traditional Chinese Medicine, Chongqing, China
  • 3Henan University of Chinese Medicine, Zhengzhou, China

The final, formatted version of the article will be published soon.

Childhood obesity has emerged as a major global public health crisis. Current assessment methods, primarily relying on Body Mass Index (BMI), significantly limit the effectiveness of risk stratification and treatment due to their inability to capture the notable clinical heterogeneity of this condition. To address this, this review aims to propose a conceptual framework for pediatric obesity phenotypic subtypes, transcending BMI and rooted in dominant pathophysiological mechanisms, thereby offering a new theoretical basis for understanding its heterogeneity and advancing personalized medicine. Within this framework, we categorize childhood obesity into four core subtypes: 1) the "Dysmetabolic Subtype," characterized by insulin resistance and ectopic fat deposition; 2) the "Inflammatory Subtype," dominated by chronic, low-grade systemic inflammation; 3) the "Neurobehavioral Subtype," originating from central appetite and reward system dysfunction; and 4) the "Biomechanical/Structural Subtype," primarily driven by excessive mechanical load. This paper elaborates on the biological mechanisms, clinical identification pathways, key differential diagnostic points, and associations with specific long-term disease risks for each subtype. We believe that this phenotypic subtype framework provides a clear model for interpreting the diverse clinical outcomes and disease trajectories of childhood obesity. Adopting this multidimensional, multipath paradigm is a crucial step from the "one-size-fits-all" traditional management model towards a new era of precise risk assessment and personalized, "subtype-specific" treatment, which holds significant importance for improving long-term health outcomes.

Keywords: Childhood Obesity, heterogeneity, Phenotypic Subtype, precision medicine, Body mass index (BMI), metabolic syndrome, Inflammation

Received: 18 Sep 2025; Accepted: 06 Nov 2025.

Copyright: © 2025 张, zhang, Yu, Zhang, Cui and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hongtao Cui, dr.cuihongtao@qq.com
Yan Xu, superxy@hactcm.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.